Botulinum neurotoxin type A resistance: An emerging problem

ResearchPod

English - March 06, 2023 11:00 - 12 minutes - 8.28 MB
Science Technology science research outreach education stem learning academic technology impact scicomm Homepage Download Google Podcasts Overcast Castro Pocket Casts RSS feed

Previous Episode: The Impact of Gender and Bottom-line Mentality Upon Workplace Mistreatment

Next Episode: Sensitising science to research involving animals

Botulinum neurotoxin A (BoNT-A), often referred to as ‘Botox’, is increasingly in cosmetic procedures. However, long-term use and high doses of BoNT-A may lead to immunoresistance, limiting its future therapeutic benefit.

A panel of experts including Dr Mary Dingley, Cosmetic Medicine Centre, Australia, is addressing this emerging issue. They offer guidance to practitioners and promote a culture of open communication with patients about BoNT-A risks, to empower individuals to make a fully informed decision.